Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer’s disease.
INTRODUCTION: The objective of this study was to determine the utility of subjective memory decline (SMD) to predict episodic memory change and rates of clinical progression in cognitively normal older adults with evidence of high β-amyloid […]
Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.
INTRODUCTION: Three 18F-labeled radiopharmaceuticals have been Food and Drug Administration-approved for the identification of cortical amyloidosis in clinical settings. Although there has been strong debate among professionals as to the ethical and social consequences of disclosing […]